These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Targeting Myeloid Differentiation Using Potent 2-Hydroxypyrazolo[1,5- a]pyridine Scaffold-Based Human Dihydroorotate Dehydrogenase Inhibitors. Sainas S; Pippione AC; Lupino E; Giorgis M; Circosta P; Gaidano V; Goyal P; Bonanni D; Rolando B; Cignetti A; Ducime A; Andersson M; Järvå M; Friemann R; Piccinini M; Ramondetti C; Buccinnà B; Al-Karadaghi S; Boschi D; Saglio G; Lolli ML J Med Chem; 2018 Jul; 61(14):6034-6055. PubMed ID: 29939742 [TBL] [Abstract][Full Text] [Related]
6. Structural Optimization and Structure-Activity Relationship of 4-Thiazolidinone Derivatives as Novel Inhibitors of Human Dihydroorotate Dehydrogenase. Zeng F; Quan L; Yang G; Qi T; Zhang L; Li S; Li H; Zhu L; Xu X Molecules; 2019 Jul; 24(15):. PubMed ID: 31370178 [TBL] [Abstract][Full Text] [Related]
7. Design, synthesis, biological evaluation and X-ray structural studies of potent human dihydroorotate dehydrogenase inhibitors based on hydroxylated azole scaffolds. Sainas S; Pippione AC; Giorgis M; Lupino E; Goyal P; Ramondetti C; Buccinnà B; Piccinini M; Braga RC; Andrade CH; Andersson M; Moritzer AC; Friemann R; Mensa S; Al-Kadaraghi S; Boschi D; Lolli ML Eur J Med Chem; 2017 Mar; 129():287-302. PubMed ID: 28235702 [TBL] [Abstract][Full Text] [Related]
8. A novel series of teriflunomide derivatives as orally active inhibitors of human dihydroorotate dehydrogenase for the treatment of colorectal carcinoma. Li C; Zhou Y; Xu J; Zhou X; Huang Z; Zeng T; Yang X; Tao L; Gou K; Zhong X; Chen Q; Luo Y; Zhao Y Eur J Med Chem; 2022 Aug; 238():114489. PubMed ID: 35640328 [TBL] [Abstract][Full Text] [Related]
9. QSAR study on a series of aryl carboxylic acid amide derivatives as potential inhibitors of dihydroorotate dehydrogenase (DHODH). Vyas VK; Ghate M Med Chem; 2013 Mar; 9(2):222-39. PubMed ID: 22920152 [TBL] [Abstract][Full Text] [Related]
10. Development of a human dihydroorotate dehydrogenase (hDHODH) pharma-similarity index approach with scaffold-hopping strategy for the design of novel potential inhibitors. Shih KC; Lee CC; Tsai CN; Lin YS; Tang CY PLoS One; 2014; 9(2):e87960. PubMed ID: 24504131 [TBL] [Abstract][Full Text] [Related]
11. Synthesis of beta-hydroxy-propenamide derivatives and the inhibition of human dihydroorotate dehydrogenase. Kim TH; Na HS; Löffler M Arch Pharm Res; 2003 Mar; 26(3):197-201. PubMed ID: 12723931 [TBL] [Abstract][Full Text] [Related]
12. Design, synthesis and pharmacological evaluation of novel substituted quinoline-2-carboxamide derivatives as human dihydroorotate dehydrogenase (hDHODH) inhibitors and anticancer agents. Vyas VK; Variya B; Ghate MD Eur J Med Chem; 2014 Jul; 82():385-93. PubMed ID: 24929289 [TBL] [Abstract][Full Text] [Related]
13. Synthesis, Design, and Structure⁻Activity Relationship of the Pyrimidone Derivatives as Novel Selective Inhibitors of Xu L; Li W; Diao Y; Sun H; Li H; Zhu L; Zhou H; Zhao Z Molecules; 2018 May; 23(6):. PubMed ID: 29794978 [TBL] [Abstract][Full Text] [Related]
14. Tiratricol, a thyroid hormone metabolite, has potent inhibitory activity against human dihydroorotate dehydrogenase. Cao S; Ma H; Xu Z; Fang W; Huang J; Huang Y Chem Biol Drug Des; 2023 Jul; 102(1):1-13. PubMed ID: 37088711 [TBL] [Abstract][Full Text] [Related]
15. Rational Design of Benzylidenehydrazinyl-Substituted Thiazole Derivatives as Potent Inhibitors of Human Dihydroorotate Dehydrogenase with in Vivo Anti-arthritic Activity. Li S; Luan G; Ren X; Song W; Xu L; Xu M; Zhu J; Dong D; Diao Y; Liu X; Zhu L; Wang R; Zhao Z; Xu Y; Li H Sci Rep; 2015 Oct; 5():14836. PubMed ID: 26443076 [TBL] [Abstract][Full Text] [Related]
16. Discovery of a novel series of hDHODH inhibitors with anti-pulmonary fibrotic activities. Lu K; Zhao Y; Wu G; Hu H; Wang M; Gong G; Jiang Y Bioorg Chem; 2019 May; 86():44-51. PubMed ID: 30685643 [TBL] [Abstract][Full Text] [Related]
17. Targeting Acute Myelogenous Leukemia Using Potent Human Dihydroorotate Dehydrogenase Inhibitors Based on the 2-Hydroxypyrazolo[1,5- Sainas S; Giorgis M; Circosta P; Gaidano V; Bonanni D; Pippione AC; Bagnati R; Passoni A; Qiu Y; Cojocaru CF; Canepa B; Bona A; Rolando B; Mishina M; Ramondetti C; Buccinnà B; Piccinini M; Houshmand M; Cignetti A; Giraudo E; Al-Karadaghi S; Boschi D; Saglio G; Lolli ML J Med Chem; 2021 May; 64(9):5404-5428. PubMed ID: 33844533 [TBL] [Abstract][Full Text] [Related]
18. Bifunctional Naphtho[2,3- Zuo Z; Liu X; Qian X; Zeng T; Sang N; Liu H; Zhou Y; Tao L; Zhou X; Su N; Yu Y; Chen Q; Luo Y; Zhao Y J Med Chem; 2020 Jul; 63(14):7633-7652. PubMed ID: 32496056 [TBL] [Abstract][Full Text] [Related]
19. Discovery of potent human dihydroorotate dehydrogenase inhibitors based on a benzophenone scaffold. Li C; Zhou Y; Xu J; Zhou X; Liu S; Huang Z; Qiu Z; Zeng T; Gou K; Tao L; Zhong X; Yang X; Zhou Y; Su N; Chen Q; Zhao Y; Luo Y Eur J Med Chem; 2022 Dec; 243():114737. PubMed ID: 36115209 [TBL] [Abstract][Full Text] [Related]
20. Discovery a series of novel inhibitors of human dihydroorotate dehydrogenase: Biological activity evaluation and molecular docking. Ren X; Liu X; Hua M; Dai Y; Ren X; Sui C; Li X; Jiang Z; Tian M; Yang B Chem Biol Drug Des; 2024 Jan; 103(1):e14388. PubMed ID: 37926553 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]